[ORGANIZATION]
Madrigal Pharmaceuticals
Featured in 2 tracked stories · first seen
Situations
GLP-1 receptor agonist research and safety scrutiny
13 clusters · 72 sources · last updated
Latest: FDA requires GLP-1 medication warnings for rare eye condition
Research into GLP-1 receptor agonists (GLP-1 RAs) continues to expand, investigating benefits beyond glycemic control and weight loss. Potential advantages include cardiovascular protection, kidney support, reduction in
Also covered in
-
AASLD Liver Meeting highlights breakthroughs in Hepatitis B and MASH research
[HEALTH] · 2 sources ·